Gapping up
In reaction to strong earnings/guidance:
In reaction to strong earnings/guidance:
- CIDM +15.7%, IOTS +12.7%, WIX +7.5%, SODA +7.2%, IVTY +5.8%, SEDG +5.5%, ANGI +4.6%, ELOS +4.3%, CCS +3.9%, CCS +3.9%, ALKS +3.5%
- ADI +3.5%, OZM +3.3%, IOSP +3%, A +2.7%, FANG +2.4%, PBPB +2.4%, HUN +2.3%, VNOM +2.2%, BG +1.9%, SHOP +1.7%, ADHD +1.7%, DVN +1.4%
- KRNT +1.4%, WGBS +1.4%, HUM +0.7%, PAAS +0.7%, ETR +0.6%
M&A news:
- FIG +28.2% (SoftBank confirms plans to acquire Fortress Investment Group for $3.3 bln)
Select EU financial related names showing strength:
- DB +1.6%, CS +1.1%, BCS +0.9%, LYG +0.9%, HSBC +0.7%
Select Airline related names showing strength:
- LUV +2.8%, UAL +2.6%, AAL +2.5%, DAL +2%, JBLU +1.4%, SAVE +1%
Other news:
- PAH +3.2% (Elliott Management discloses new position)
- PG +2.5% (Nelson Peltz's Trian takes stake)
- SIRI +2.3% (new Berkshire Hathaway stake)
- TWTR +2.2% (CEO Jack Dorsey disclosed purchase of nearly 426K shares worth $7 mln)
- ARDX +2.2% (reports its Phase 3 trial evaluating tenapanor as a treatment for hyperphosphatemia in patients with end-stage renal disease who are on dialysis met its primary endpoint and was generally well-tolerated)
- NTCT +1.2% (ValueAct new position),
- FOLD +1.1% (reports new positive data analyses for the oral small molecule pharmacological chaperone migalastat HCl for Fabry disease)
- CRM +1% (new Corvex stake)
- MON +1% (new Berkshire Hathaway stake)
- HTZ +0.9% (Icahn increases stake)
Analyst comments:
- RH +3% (upgraded to Overweight from Sector Weight at KeyBanc Capital Mkts)
- OLED +2.2% (initiated with a Positive at Susquehanna; tgt $100)
- BBVA +2% (upgraded to Overweight from Neutral at JP Morgan)
- PH +1.5% (upgraded to Buy from Neutral at BofA/Merrill)
- V +0.6% (initiated with Buy ratings at Loop Capital)
- NDSN +0.5% (upgraded to Overweight from Sector Weight at KeyBanc Capital Mkts)